What You Should Know:
- The Leona M. and Harry B. Helmsley Charitable Trust announced a major initiative to improve the lives of people with type 1 diabetes (T1D) by awarding $12 million in grants to support research on safely incorporating exercise into their lives.
- The Helmsley Charitable Trust is the world's largest private foundation dedicated to funding T1D research. With this latest initiative, the Trust has committed over $1 billion to support research efforts aimed at
Read More
Digital Health | News, Analysis, Insights - HIT Consultant
CitiusTech Launches Generative AI Quality & Trust Solution
What You Should Know:
- CitiusTech, a healthcare technology provider, has unveiled a groundbreaking solution to address the reliability, quality, and trust concerns surrounding Generative AI (Gen AI) in healthcare.
- This industry-first offering aims to empower healthcare organizations to confidently adopt and scale Gen AI applications, unlocking their transformative potential.
Gen AI Quality & Trust Solution
Over 80% of Gen AI projects face delays due to lack of trust in their
Read More
Everly Health Expands Kidney Health Testing with NFK Partnership
What You Should Know:
Everly Health, a leading remote-based healthcare company expanding access to virtual-first disease prevention, diagnosis, and treatment, today announced an educational partnership with the National Kidney Foundation aimed at informing Americans about chronic kidney disease and increasing access to screening in rural and underserved communities across the United States.Kidney disease affects 37 million adults in the United States but 90% are unaware they even have it
Read More
FDA Clears Proscia’s Digital Pathology Solution for Cancer Diagnosis
What You Should Know:
Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) clearance from the United States (U.S.) Food and Drug Administration (FDA) for its Concentriq® AP-Dx*. The digital pathology solution was cleared for the purpose of primary diagnosis.Proscia’s Concentriq AP-Dx is a comprehensive diagnostic software solution that immerses pathologists in an intuitive experience for viewing, interpreting, and managing whole slide images
Read More
FHIR Adoption on the Rise: ONC Survey Shows Digital Health Companies Embrace Standards-Based APIs
What You Should Know:
- A new survey reveals that the healthcare industry is making significant strides towards interoperability, thanks to the adoption of standards-based application programming interfaces (APIs).
- The research, conducted by the Office of the National Coordinator for Health Information Technology (ONC), reveals that a majority of digital health companies are using the FHIR standard to integrate with electronic health records (EHRs).
The Rise of FHIR
The Cures Act
Read More
GoodRx Offers 30 Meds Under $30 for Heart Conditions
What You Should Know:
GoodRx, a prescription savings platform, is stepping up to help with a new program offering 30 common heart health medications for under $30 at over 70,000 pharmacies nationwide.
Making Heart Health Affordable
- GoodRx recognizes the financial burden of managing heart disease and aims to improve access to affordable medications. By offering significant discounts on both generic and brand-name drugs, they target conditions like coronary artery disease, high
Read More
Health Systems Grapple with AI Governance: Balancing Promise and Risk
What You Should Know:
- Despite the increasing adoption of artificial intelligence (AI) in healthcare, a new survey reveals that very few health systems have formal policies in place to govern its use, particularly for generative AI. In addition, 70% of executives plan to adopt AI solutions through EHR vendors for easier integration.
- The Center for Connected Medicine's full report, "How Health Systems are Navigating the Complexities of AI," offers a deeper dive into the survey findings
Read More
Insilico’s Potential Best-in-Class AI Drug for Sought-After Cancer Target
What You Should Know:
InSilico Medicine, a clinical-stage company utilizing generative artificial intelligence (AI) for drug discovery, reveals the development of an orally bioavailable preclinical candidate compound. This compound targets KIF18A and aims to treat advanced solid tumors characterized by TP53 mutation.The development is particularly significant for high-grade serous ovarian cancer (HGSOC), triple-negative breast cancer (TNBC), and non-small cell lung cancer
Read More
WellSpan Health Taps Biofourmis to Expand Hospital-at-Home Program
What You Should Know:
- WellSpan Health, a technologically advanced healthcare system, has partnered with Biofourmis to expand its award-winning hospital-at-home program.
- The strategic collaboration will leverage Biofourmis' remote patient management platform to streamline care delivery, improve patient outcomes, and reduce readmission rates.
Partnership Details
WellSpan currently manages one of the largest hospital-at-home programs in the U.S., caring for over 400 patients
Read More
VR Mask for PTSD Shows Promise in Decentralized Trial, Aims for FDA Breakthrough Designation
What You Should Know:
- Curavit Clinical Research, a leader in decentralized clinical trials (DCTs) for digital therapeutics (DTx), successfully completed a study for the Sana Device, a virtual reality (VR) mask aiming to reduce post-traumatic stress disorder (PTSD) symptoms.
- Overall, this study represents a significant step forward in the development of VR-based treatments for PTSD. If approved, the Sana Device could offer a valuable tool for patients struggling with this
Read More
